Yamashiro K, Takahashi H, Rinno Y, Origasa H, Izumi K, Tajima N, Nishimura R. A large-scale, observational study to investigate the current status of diabetes complication and their prevention in japan: incidence/risk factors for malignancies during follow-up—JDCP study 11. J Jpn Diabetes Soc. 2023;66:655–66 (in Japanese).
Noto H, Tsujimoto T, Noda M. Significantly increased risk of cancer in diabetes mellitus patients: a meta-analysis of epidemiological evidence in Asians and non-Asians. J ournal of Diabetes Investig. 2012;3:24–33.
Noto H, Goto A, Tsujimoto T, Osame K, Noda M. Latest insights into the risk of cancer in diabetes. J Diabetes Investig. 2013;4:225–323.
PubMed PubMed Central Google Scholar
Chen Y, Wu F, Saito E, Lin Y, Song M, Luu HN, Gupta PC, Sawada N, Tamakoshi A, Shu XO, Koh WP, Xiang YB, Tomata Y, Sugiyama K, Park SK, Matsuo K, Nagata C, Sugawara Y, Qiao YL, You SL, Wang R, Shin MH, Pan WH, Pednekar MS, Tsugane S, Cai H, Yuan JM, Gao YT, Tsuji I, Kanemura S, Ito H, Wada K, Ahn YO, Yoo KY, Ahsan H, Chia KS, Boffetta P, Zheng W, Inoue M, Kang D, Potter JD. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia. 2017;60:1022–32.
PubMed PubMed Central Google Scholar
Rao Kondapally Seshasai S, Kaptoge S, Thomp-son A, di Angelantonio E, Gao P, Sar-war N, Fletch-er A, Lewington S, Collins R, Selvin E, Danesh J. Diabetes mellitus, fasting glucose, and risk of cause-specific death A BS T R AC T. N Engl J Med. 2011;364:829–41.
PubMed PubMed Central Google Scholar
Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Hui Li, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371:1783–9.
Nakamura J, Kamiya H, Haneda M, Inagaki N, Tanizawa Y, Araki E, Ueki K, Nakayama T. Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: report of the Committee on Causes of Death in Diabetes Mellitus. J Diabetes Investig. 2017;8:397–410.
CAS PubMed PubMed Central Google Scholar
Tseng CH. Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care. 2004;27:1605–9.
Noto H, Osame K, Sasazuki T, Noda MT. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complic. 2010;24:345–53.
Noto H, Tsujimoto T, Sasazuki T, Noda M. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract. 2011;17:616–28.
Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33:1674–85.
PubMed PubMed Central Google Scholar
Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010;60:207–21.
Kasuga M, Ueki K, Tajima N, Noda M, Ohashi K, Noto H, Goto A, Ogawa W, Sakai R, Tsugane S, Hamajima N, Nakagama H, Tajima K, Miyazono K, Imai K. Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer. Cancer Sci. 2013;104:965–76.
CAS PubMed PubMed Central Google Scholar
Sasazuki S, Charvat H, Hara A, Wakai K, Nagata C, Nakamura K, Tsuji I, Sugawara Y, Tamakoshi A, Matsuo K, Oze I, Mizoue T, Tanaka K, Inoue M, Tsugane S. Diabetes mellitus and cancer risk: pooled analysis of eight cohort studies in Japan. Cancer Sci. 2013;104:1499–507.
CAS PubMed PubMed Central Google Scholar
Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121:856–62.
Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomark Prev. 2006;15:2056–62.
Tajima N, Nishimura R, Izumi K, Hayashino Y, Origasa H, Noda M, Ueki K. A large-scale, observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 2 diabetes: JDCP study 1. Diabetol Int. 2015;6:243–51.
The R Project for Statistical Computing. https://www.r-project.org.
Brown ER, Ibrahim JG, DeGruttola V. A flexible B-spline model for multiple longitudinal biomarkers and survival. Biometrics. 2005;61:64–73.
Heinz H, Kaider A. Gaining more flexibility in ~COX proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed. 1997;54:201–8.
Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–91.
Iwase M, Fujii H, Idewaki Y, Nakamura U, Ohkuma T, Ide H, Komorita Y, Jodai-Kitamura T, Yoshinari M, Kitazono T. Prospective study of cancer in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetol Int. 2019;10:260–7.
PubMed PubMed Central Google Scholar
DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding SA, Jemal A, Siegel RL. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69:438–51.
Bae JM. History of diabetes mellitus and risk of breast cancer in Asian women: a meta-epidemiological analysis of population-based cohort studies. J Menopausal Med. 2020;26:29.
PubMed PubMed Central Google Scholar
Kang C, LeRoith D, Gallagher EJ. Diabetes, obesity, and breast cancer. Endocrinology. 2018;159:3801–12.
CAS PubMed PubMed Central Google Scholar
Xu H, Jiang H-W, Ding G-X, Zhang H, Zhang L-M, Mao S-H, Ding Q. Diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2013;99:241–9.
Rastad H, Parsaeian M, Shirzad N, Mansournia MA, Yazdani K. Diabetes mellitus and cancer incidence: the Atherosclerosis Risk in Communities (ARIC) cohort study. J Diabetes Metab Disord. 2019;18:65–72.
PubMed PubMed Central Google Scholar
Long XJ, Lin S, Sun YN, Zheng ZF. Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:4097–100.
Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011;332:1519–23.
CAS PubMed PubMed Central Google Scholar
Lu S, Wang A, Miao S, Zhang X, Jing S, Shan T, Guo Y, Liu Y. Association between type 2 diabetes and cancer incidence in China: data in hospitalized patients from 2006 to 2013. Ann Transl Med. 2020;8:176–176.
CAS PubMed PubMed Central Google Scholar
Ohkuma T, Peters SAE, Woodward M. Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events. Diabetologia. 2018;61:2140–54.
PubMed PubMed Central Google Scholar
Krämer HU, Raum E, Rüter G, Schöttker B, Rothenbacher D, Rosemann T, Szecsenyi J, Brenner H. Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study. Cardiovasc Diabetol. 2012;11:88.
PubMed PubMed Central Google Scholar
Kautzky-Willer A, Kamyar MR, Gerhat D, Handisurya A, Stemer G, Hudson S, Luger A, Lemmens-Gruber R. Sex-Specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus. Gend Med. 2010;7:571–83.
Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, Aubert RE. Determinants of adherence to diabetes medications: Findings from a large pharmacy claims database. Diabetes Care. 2015;38:604–9.
PubMed PubMed Central Google Scholar
Aomi N, Emura U, Kamoto HO, Oichiro S, Amamoto Y, Obutoshi N, Atsumura M, Huji S, Amaguchi Y, Ichio M, Amakido Y, Iyomi K, Aniyama T, Asaki S, Chlemper JS. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.
Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Eng J Med. 1993;328:1797–801.
Lykoudis P, Contis J. Estrogen receptor expression in pancreatic adenocarcinoma: time to reconsider evidence. Pancreas. 2010;50:1250–3.
Lim HK, Kwon HJ, Lee GS, Moon JH, Jung J. Chrysin-induced g protein-coupled estrogen receptor activation suppresses pancreatic cancer. Int J Mol Sci. 2022;23:9673.
CAS PubMed PubMed Central Google Scholar
Wang R, Gao D, Zhou Y, Chen L, Luo B, Yu Y, Li H, Hu J, Huang Q, He M, Peng W, Luo D. High glucose impaired estrogen receptor alpha signaling via β-catenin in osteoblastic MC3T3-E1. J Steroid Biochem Mol Biol. 2017;174:276–83.
Comments (0)